Patent · US Active

2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections

US8841275B2 · kind B2 · utility

52Cited by
171References
57Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2011
Grant dateSep 23, 2014
Priority date—
Expiry dateMar 10, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are 2′-spiro-nucleosides and derivatives thereof useful for treating a subject infected by hepatitis C virus or dengue virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.